Annexon, Inc. (ANNX)
NASDAQ: ANNX · IEX Real-Time Price · USD
4.565
-0.485 (-9.60%)
At close: Jul 2, 2024, 4:00 PM
4.560
-0.005 (-0.11%)
After-hours: Jul 2, 2024, 7:27 PM EDT
Annexon Market Cap
Annexon has a market cap or net worth of $481.21 million as of July 2, 2024. Its market cap has increased by 160.54% in one year.
Market Cap
481.21M
Enterprise Value
246.02M
1-Year Change
160.54%
Ranking
Category
Stock Price
$4.57
Market Cap Chart
Since July 24, 2020, Annexon's market cap has decreased from $599.60M to $481.21M, a decrease of -19.74%. That is a compound annual growth rate of -5.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 466.70M | 93.09% |
| Dec 29, 2023 | 241.70M | -1.83% |
| Dec 30, 2022 | 246.20M | -44.16% |
| Dec 31, 2021 | 440.90M | -53.84% |
| Dec 31, 2020 | 955.10M | 59.29% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| REGENXBIO | 545.26M |
| iTeos Therapeutics | 542.20M |
| Pharming Group | 542.12M |
| Contineum Therapeutics | 540.19M |
| SIGA Technologies | 536.97M |
| Entrada Therapeutics | 531.64M |
| SI-BONE | 531.54M |
| Adaptive Biotechnologies | 530.52M |